These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4056318)

  • 1. [Lanthony's New Color Test. V. Classification of the grays].
    Pinckers A; Verriest G
    J Fr Ophtalmol; 1985; 8(3):263-5. PubMed ID: 4056318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A differential color flicker test for detecting acquired color vision impairment in multiple sclerosis and diabetic retinopathy.
    Gregori B; Papazachariadis O; Farruggia A; Accornero N
    J Neurol Sci; 2011 Jan; 300(1-2):130-4. PubMed ID: 20875905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colored stimulation points within the central visual field in recovered retrobulbar neuritis and in strabismic amblyopia--a comparison].
    Grützner P; Deuker W; Deuker HH
    Fortschr Ophthalmol; 1983; 79(6):522-4. PubMed ID: 6873822
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
    Flanagan P; Zele AJ
    Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of clinical tests of color vision in multiple sclerosis].
    Pinckers A; Verriest G
    Bull Soc Belge Ophtalmol; 1982; 199-200():131-44. PubMed ID: 6985030
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
    Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
    Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lanthony's new color test. IV. Neutral zone and neutral grays.
    Pinckers A
    Ophthalmologica; 1982; 184(1):51-7. PubMed ID: 6976544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
    Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
    Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal contrast sensitivity in optic neuritis and amblyopia.
    Kayazawa F; Yamamoto T; Itoi M
    Ann Ophthalmol; 1983 Apr; 15(4):331-4. PubMed ID: 6660704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of vision and pupil responses in optic neuritis and multiple sclerosis.
    Moro SI; Rodriguez-Carmona ML; Frost EC; Plant GT; Barbur JL
    Ophthalmic Physiol Opt; 2007 Sep; 27(5):451-60. PubMed ID: 17718884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lanthony's new color test. Part I.
    Pinckers A
    Ophthalmologica; 1978; 177(5):284-91. PubMed ID: 740362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME; Haegerstrom-Portnoy G
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial.
    Cole SR; Beck RW; Moke PS; Gal RL; Long DT
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1017-21. PubMed ID: 10752936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography in optic neuritis.
    Noval S; Contreras I; Rebolleda G; Muñoz-Negrete FJ
    Ophthalmology; 2007 Jan; 114(1):200. PubMed ID: 17198866
    [No Abstract]   [Full Text] [Related]  

  • 15. Lanthony's new color test--part III. The neutral zone.
    Pinckers A
    Int Ophthalmol; 1979 Jul; 1(3):179-83. PubMed ID: 317903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colour vision abnormalities in multiple sclerosis.
    Harrison AC; Becker WJ; Stell WK
    Can J Neurol Sci; 1987 Aug; 14(3):279-85. PubMed ID: 3664369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of reduced viewing time on colour vision in normal subjects and those with abnormal ocular conditions.
    Taylor S
    Ophthalmic Physiol Opt; 1983; 3(3):357-60. PubMed ID: 6646771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The visual-evoked cortical potential to colour stimuli in multiple sclerosis and optic neuritis.
    Tarr KH; Hidajat RR; Goode DH
    Trans Ophthalmol Soc N Z; 1984; 36():13-5. PubMed ID: 6591605
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed pattern-evoked responses in optic neuritis in relation to visual acuity.
    Halliday AM; McDonald WI; Mushin J
    Trans Ophthalmol Soc U K (1962); 1973; 93(0):315-24. PubMed ID: 4526453
    [No Abstract]   [Full Text] [Related]  

  • 20. Local and non-local deficits in amblyopia: acuity and spatial interactions.
    Bonneh YS; Sagi D; Polat U
    Vision Res; 2004 Dec; 44(27):3099-110. PubMed ID: 15482798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.